(19)
(11) EP 4 072 604 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.03.2024 Bulletin 2024/13

(45) Mention of the grant of the patent:
21.02.2024 Bulletin 2024/08

(21) Application number: 20824657.9

(22) Date of filing: 04.12.2020
(51) International Patent Classification (IPC): 
A61L 15/18(2006.01)
A01N 59/16(2006.01)
A61L 15/42(2006.01)
A01N 25/34(2006.01)
A01N 59/20(2006.01)
A61L 15/44(2006.01)
(52) Cooperative Patent Classification (CPC):
A61L 15/44; A61L 15/18; A61L 15/42; A61L 2300/104; A61L 2300/404; A61L 2300/60; A61L 2300/80; A01N 25/34
 
C-Sets:
A01N 25/34, A01N 59/16, A01N 59/20;
(86) International application number:
PCT/IB2020/061536
(87) International publication number:
WO 2021/116861 (17.06.2021 Gazette 2021/24)

(54)

ANTI-MICROBIAL ARTICLES

ANTIMIKROBIELLE ARTIKEL

ARTICLES ANTIMICROBIENS


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 09.12.2019 US 201962945435 P

(43) Date of publication of application:
19.10.2022 Bulletin 2022/42

(73) Proprietor: Solventum Intellectual Properties Company
Maplewood, MN 55144 (US)

(72) Inventors:
  • DAI, Minghua
    Saint Paul, Minnesota 55133-3427 (US)
  • LIU, Jie J.
    Saint Paul, Minnesota 55133-3427 (US)
  • SPAGNOLA, Joseph C.
    Saint Paul, Minnesota 55133-3427 (US)
  • OLSON, Stephen A. O.
    Saint Paul, Minnesota 55133-3427 (US)
  • YU, Ta-Hua
    Saint Paul, Minnesota 55133-3427 (US)
  • LIU, Junkang J.
    Saint Paul, Minnesota 55133-3427 (US)
  • ZHANG, Lei
    Shanghai 200336 (CN)

(74) Representative: Mathys & Squire 
Theatinerstraße 7
80333 München
80333 München (DE)


(56) References cited: : 
EP-A1- 0 427 858
WO-A1-2018/075259
WO-A1-2005/079913
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).